Supplementary Data from Therapeutic Targeting of MDR1 Expression by RORγ Antagonists Resensitizes Cross-Resistant CRPC to Taxane Via Coordinated Induction of Cell Death Programs

Yongqiang Wang,Zenghong Huang,Christopher Z. Chen,Chengfei Liu,Christopher P. Evans,Allen C. Gao,Fangjian Zhou,Hongwu Chen

DOI: https://doi.org/10.1158/1535-7163.22506840.v1

2023-01-01

Abstract:Supplementary Figures and Tables

What problem does this paper attempt to address?

Supplementary Data from an Alternatively Spliced P62 Isoform Confers Resistance to Chemotherapy in Breast Cancer

Qianying Guo,Hao Wang,Jiahao Duan,Wenwu Luo,Rongrong Zhao,Yuting Shen,Bijun Wang,Siqi Tao,Yi Sun,Qian Ye,Xiaomin Bi,Hui Yuan,Qiang Wu,Peter E. Lobie,Tao Zhu,Sheng Tan,Xing Huang,Zhengsheng Wu

DOI: https://doi.org/10.1158/0008-5472.22432764.v1

2023-01-01

Abstract:Supplementary Data from An Alternatively Spliced p62 Isoform Confers Resistance to Chemotherapy in Breast Cancer
Supplementary Figure S4 from Combination Therapy Targeting Ribosome Biogenesis and Mrna Translation Synergistically Extends Survival in MYC-Driven Lymphoma

Jennifer R. Devlin,Katherine M. Hannan,Nadine Hein,Carleen Cullinane,Eric Kusnadi,Pui Yee Ng,Amee J. George,Jake Shortt,Megan J. Bywater,Gretchen Poortinga,Elaine Sanij,Jian Kang,Denis Drygin,Sean O'Brien,Ricky W. Johnstone,Grant A. McArthur,Ross D. Hannan,Richard B. Pearson

DOI: https://doi.org/10.1158/2159-8290.22530950

2023-01-01

Abstract:This figure shows supplementary data pertinent to Figure 4 including protein and cell death analysis data.
Supplementary Fig. 7 from Discovery and Targeting of a Noncanonical Mechanism of Sarcoma Resistance to ADI-PEG20 Mediated by the Microenvironment

Leonard C. Rogers,Jeff C. Kremer,Caitlyn B. Brashears,Zongtao Lin,Zhixian Hu,Alliny C.S. Bastos,Adriana Baker,Nicole Fettig,Dong Zhou,Kooresh I. Shoghi,Carina A. Dehner,John S.A. Chrisinger,John S. Bomalaski,Benjamin A. Garcia,Toshinao Oyama,Eileen P. White,Brian A. Van Tine

DOI: https://doi.org/10.1158/1078-0432.23952321.v1

2023-01-01

Abstract:Supplemental Figure 7. Gemcitabine and docetaxel increase toxicity to ASS1 KO tumor cells treated with ADI-PEG20 and either chloroquine or imipramine.
Supplementary Figure S3 from Combination Therapy Targeting Ribosome Biogenesis and Mrna Translation Synergistically Extends Survival in MYC-Driven Lymphoma

Jennifer R. Devlin,Katherine M. Hannan,Nadine Hein,Carleen Cullinane,Eric Kusnadi,Pui Yee Ng,Amee J. George,Jake Shortt,Megan J. Bywater,Gretchen Poortinga,Elaine Sanij,Jian Kang,Denis Drygin,Sean O'Brien,Ricky W. Johnstone,Grant A. McArthur,Ross D. Hannan,Richard B. Pearson

DOI: https://doi.org/10.1158/2159-8290.22530953

2023-01-01

Abstract:This figure shows supplementary data pertinent to Figure 3 including protein and cell immunofluorescence analysis data.
Supplementary Data from Regorafenib Promotes Antitumor Immunity Via Inhibiting PD-L1 and IDO1 Expression in Melanoma

Rui-Yan Wu,Peng-Fei Kong,Liang-Ping Xia,Yun Huang,Zhi-Ling Li,Yun-Yun Tang,Yu-Hong Chen,Xuan Li,Ravichandran Senthilkumar,Hai-Liang Zhang,Ting Sun,Xue-Lian Xu,Yan Yu,Jia Mai,Xiao-Dan Peng,Dong Yang,Li-Huan Zhou,Gong-Kan Feng,Rong Deng,Xiao-Feng Zhu

DOI: https://doi.org/10.1158/1078-0432.22471275.v1

2023-01-01

Abstract:Supplementary Figures + Supplementary Datas
Supplementary Figures from Targeting Triple-Negative Breast Cancer with Combination Therapy of EGFR CAR T Cells and CDK7 Inhibition

Xin Lin,Zaozao Zheng,Junyi Liu,Yujie Chen,Junqiang Ding,Guosheng Hu,Yahong Hu,Suling Liu,Wenxin Luo,Ningshao Xia,Wen Li

DOI: https://doi.org/10.1158/2326-6066.22543596.v1

2023-01-01

Abstract:All Supplementary Figures (1-9)
Supplementary Data from Targeting Squalene Epoxidase Interrupts Homologous Recombination Via the ER Stress Response and Promotes Radiotherapy Efficacy

Zhipeng Hong,Tao Liu,Lingfeng Wan,Pengyan Fa,Pankaj Kumar,Yanan Cao,Chandra Bhushan Prasad,Zhaojun Qiu,Joseph Liu,Hongbing Wang,Zaibo Li,Qi-En Wang,Peixuan Guo,Deliang Guo,Ayse S. Yilmaz,Lanchun Lu,Ioanna Papandreou,Naduparambil K. Jacob,Chunhong Yan,Xiaoli Zhang,Qing-Bai She,Zhefu Ma,Junran Zhang

DOI: https://doi.org/10.1158/0008-5472.22430871.v1

2023-01-01

Abstract:Supplementary Data from Targeting Squalene Epoxidase Interrupts Homologous Recombination via the ER Stress Response and Promotes Radiotherapy Efficacy
Supplementary Figure 8 from Discovery of a Mutant-Selective Covalent Inhibitor of EGFR That Overcomes T790M-Mediated Resistance in NSCLC

Annette O. Walter,Robert Tjin Tham Sjin,Henry J. Haringsma,Kadoaki Ohashi,Jun Sun,Kwang‐Ho Lee,Aleksandr Dubrovskiy,Matthew Labenski,Zhihong Zhu,Zhigang Wang,Michael Sheets,Thomas N. Martin,Russell Karp,Dan van Kalken,Prasoon Chaturvedi,Deqiang Niu,Mariana Nacht,Russell C. Petter,William Westlin,Kevin Lin,Sarah Jaw‐Tsai,Mitch Raponi,Terry Van Dyke,Jeff Etter,Zoë Weaver,William Pao,Juswinder Singh,Andrew Simmons,Thomas C. Harding,Andrew J. Allen

DOI: https://doi.org/10.1158/2159-8290.22530288.v1

2023-01-01

Abstract:Supplementary Figure 8 - PDF file 215K, Photomicrographs of CO-1686 resistant NCI-H1975 cell (COR) clones and quantification of EGFR siRNA knockdown in COR clones
Suppl. Figure 2 from Inhibition of REDD1 Sensitizes Bladder Urothelial Carcinoma to Paclitaxel by Inhibiting Autophagy

Qinghai Zeng,Jianye Liu,Peng Cao,Jingjing Li,Xiaoming Liu,Xiaodong Fan,Ling Liu,Yan Chen,Wei Xiong,Jigang Li,Bo Hu,Yan Zhu,Fei Yang,Jun Hu,Ming Zhou,Yanhong Zhou,Qiong Zou,Jianda Zhou,Ke Cao

DOI: https://doi.org/10.1158/1078-0432.22466948

2023-01-01

Abstract:(A) The mutation sites in the REDD1 3'UTR reporter construct. (B) The cytotoxicity test of Taxol in T24 and RT4 cells. Cell proliferation was determined in T24 and RT4 cells using the CCK-8 method.
Supplementary Data from Inhibition of ACAA1 Restrains Proliferation and Potentiates the Response to CDK4/6 Inhibitors in Triple-Negative Breast Cancer

Weiping Peng,Xi Jin,Xiao‐En Xu,Yingju Yang,Ding Ma,Zhi‐Ming Shao,Yi‐Zhou Jiang

DOI: https://doi.org/10.1158/0008-5472.22732543

2023-01-01

Abstract:Supplementary methods, figures, figure legends, and tables
Supplementary Figure S6 from Targeted Therapy of &Lt;i>tert</i>-Rearranged Neuroblastoma with BET Bromodomain Inhibitor and Proteasome Inhibitor Combination Therapy

Jingwei Chen,Christopher P. Nelson,Matthew Wong,Andrew E. Tee,Pei Y. Liu,Ting La,Jamie I. Fletcher,Alvin Kamili,Chelsea Mayoh,Christoph Bartenhagen,Toby N. Trahair,Ning Xu,Nisitha Jayatilleke,Marie Wong,Pei Hui,Bernard Atmadibrata,Belamy B. Cheung,Qing Lan,Tracy M. Bryan,Pieter Mestdagh,Jo Vandesompele,Valérie Combaret,Valentina Boeva,Jenny Wang,Isabelle Janoueix-Lerosey,Mark J. Cowley,Karen L. MacKenzie,Alla Dolnikov,Jinyan Li,Patsie Polly,Glenn M. Marshall,Roger R. Reddel,Murray D. Norris,Michelle Haber,Matthias Fischer,Xu Dong Zhang,Hilda A. Pickett,Tao Liu

DOI: https://doi.org/10.1158/1078-0432.22479837.v1

2023-01-01

Abstract:Supplementary Figure S6. OTX015 and carfilzomib exert synergistic anticancer effects partly by inducing oxidative stress and endoplasmic reticulum stress.
Supplementary Figure 2 from SMAC Mimetic (JP1201) Sensitizes Non–Small Cell Lung Cancers to Multiple Chemotherapy Agents in an IAP-Dependent but TNF-α–Independent Manner

Rachel M. Greer,Michael Peyton,Jill E. Larsen,Luc Girard,Yang Xie,Adi F. Gazdar,Patrick G. Harran,Lai Wang,Rolf A. Brekken,Xiaodong Wang,John D. Minna

DOI: https://doi.org/10.1158/0008-5472.22391381

2023-01-01

Abstract:PDF file - 671K, A, H358, D, H1819, G, H2887 treated with gemcitabine alone (brown circles), or treated with gemcitabine in the presence of 10 mM JP1201 (red diamonds), luciferase siRNA (black circles), cIAP1 siRNA (blue triangles), cIAP2 siRNA (grey triangles), XIAP siRNA (green squares), or the combination of cIAP1, cIAP2, and XIAP siRNA (orange squares). B, H358, E, H1819, H, H2887 treated with paclitaxel alone (brown circles), or treated with paclitaxel in the presence of 10 mM JP1201 (red diamonds), luciferase siRNA (black circles), cIAP1 siRNA (blue triangles), cIAP2 siRNA (grey triangles), XIAP siRNA (green squares), or the combination of cIAP1, cIAP2, and XIAP siRNA (orange squares). C, H358, F, H1819, I, H2887 treated with vinorelbin alone (brown circles), or treated with vinorelbine in the presence of 10 mM JP1201 (red diamonds), luciferase siRNA (black circles), cIAP1 siRNA (blue triangles), cIAP2 siRNA (grey triangles), XIAP siRNA (green squares), or the combination of cIAP1, cIAP2, and XIAP siRNA (orange squares).
Targeting CXCR4 abrogates resistance to trastuzumab by blocking cell cycle progression and synergizes with docetaxel in breast cancer treatment

Shuying Liu,Shelly M. Xie,Wenbin Liu,Mihai Gagea,Ariella B. Hanker,Nguyen Nguyen,Akshara Singareeka Raghavendra,Gloria Yang-Kolodji,Fuliang Chu,Sattva S. Neelapu,Adriano Marchese,Samir Hanash,Johann Zimmermann,Carlos L. Arteaga,Debasish Tripathy

DOI: https://doi.org/10.1186/s13058-023-01665-w

2023-06-07

Breast Cancer Research

Abstract:Although trastuzumab and other HER2-targeted therapies have significantly improved survival in patients with HER2 overexpressed or amplified (HER2+) breast cancer, a significant proportion of patients do not respond or eventually develop clinical resistance. Strategies to reverse trastuzumab resistance remain a high clinical priority. We were the first to report the role of CXCR4 in trastuzumab resistance. The present study aims to explore the therapeutic potential of targeting CXCR4 and better understand the associated mechanisms.

oncology
Supplementary Data from Targeting Fc Receptor-Mediated Effects and the “don't Eat Me” Signal with an Oncolytic Virus Expressing an Anti-CD47 Antibody to Treat Metastatic Ovarian Cancer

Tian Liu,Bo Xu,Kun‐Yu Teng,Mi‐Yeon Song,Zheng Zhu,Yuqing Chen,Jing Wang,Jianying Zhang,Feng Mao,Balveen Kaur,Lorna Rodriguez,Michael A. Caligiuri,Jianhua Yu

DOI: https://doi.org/10.1158/1078-0432.22483347.v1

2023-01-01

Abstract:All supplementary data: supplementary figures s1-s13 and table s1
Supplementary Figure 3 from PPARγ Ligand–induced Annexin A1 Expression Determines Chemotherapy Response Via Deubiquitination of Death Domain Kinase RIP in Triple-negative Breast Cancers

Luxi Chen,Yi Yuan,Shreya Kar,Madhu M. Kanchi,Suruchi Arora,Ji E. Kim,Pei F. Koh,Einas Yousef,Ramar P. Samy,Muthu K. Shanmugam,Tuan Z. Tan,Sung W. Shin,Frank Arfuso,Han M. Shen,Henry Yang,Boon C. Goh,Joo I. Park,Louis Gaboury,Peter E. Lobie,Gautam Sethi,Lina H.K. Lim,Alan P. Kumar

DOI: https://doi.org/10.1158/1535-7163.22509313

2023-01-01

Abstract:Supplementary Figure 3: PPARγ induced expression of ANXA1 and cell death is abrogated in TNBC cells with pre-incubation of a PPARγ-specific antagonist or use of a dominant negative derivative of PPARγ.
Supplementary Tables 1 Through 4 from Mir200c Attenuates P-gp–Mediated MDR and Metastasis by Targeting JNK2/c-Jun Signaling Pathway in Colorectal Cancer

Hua Sui,Guo-Xiang Cai,Shu-Fang Pan,Wan-Li Deng,Yu-Wei Wang,Zhe-Sheng Chen,San-Jun Cai,Hui-Rong Zhu,Qi Li

DOI: https://doi.org/10.1158/1535-7163.22501848.v1

2023-01-01

Abstract:Supplementary Tables 1 through 4: Resistance to chemotherapeutic drugs in HCT8/V and HCT116/MDR cells.
Supplementary Figure 9 from Discovery of a Mutant-Selective Covalent Inhibitor of EGFR That Overcomes T790M-Mediated Resistance in NSCLC

Annette O. Walter,Robert Tjin Tham Sjin,Henry J. Haringsma,Kadoaki Ohashi,Jun Sun,Kwang‐Ho Lee,Aleksandr Dubrovskiy,Matthew Labenski,Zhihong Zhu,Zhigang Wang,Michael Sheets,Thomas N. Martin,Russell Karp,Dan van Kalken,Prasoon Chaturvedi,Deqiang Niu,Mariana Nacht,Russell C. Petter,William Westlin,Kevin Lin,Sarah Jaw‐Tsai,Mitch Raponi,Terry Van Dyke,Jeff Etter,Zoë Weaver,William Pao,Juswinder Singh,Andrew D. Simmons,Thomas C. Harding,Andrew J. Allen

DOI: https://doi.org/10.1158/2159-8290.22530285.v1

2023-01-01

Abstract:Supplementary Figure 9 - PDF file 168K, NCI-H1975 parental and CO-1686 resistant clones cluster into distinct groups using an RNA-based EMT signature
Figure S3 from Retinoic Acid–Related Orphan Receptor C Regulates Proliferation, Glycolysis, and Chemoresistance Via the PD-L1/ITGB6/STAT3 Signaling Axis in Bladder Cancer

Dalong Cao,Zihao Qi,Yangyang Pang,Haoran Li,Huyang Xie,Junlong Wu,Yongqiang Huang,Yao Zhu,Yijun Shen,Yiping Zhu,Bo Dai,Xin Hu,Dingwei Ye,Ziliang Wang

DOI: https://doi.org/10.1158/0008-5472.22418982

2023-01-01

Abstract:RORC Sensitizes Bladder Cancer Cells to Cisplatin
Supplementary Data from Galectin-3 Targeted Therapy with a Small Molecule Inhibitor Activates Apoptosis and Enhances Both Chemosensitivity and Radiosensitivity in Papillary Thyroid Cancer

Chi‐Iou Lin,Edward E. Whang,David B. Donner,Xiaofeng Jiang,Brendan D. Price,Adelaide M. Carothers,Tamara Delaine,Hakon Leffler,Ulf J. Nilsson,Vânia Nosé,Francis D. Moore,Daniel T. Ruan

DOI: https://doi.org/10.1158/1541-7786.22520788

2023-01-01

Abstract:Supplementary Data from Galectin-3 Targeted Therapy with a Small Molecule Inhibitor Activates Apoptosis and Enhances Both Chemosensitivity and Radiosensitivity in Papillary Thyroid Cancer
Supplementary Data from Protein Phosphatase 1 Subunit PPP1R14B Stabilizes STMN1 to Promote Progression and Paclitaxel Resistance in Triple-Negative Breast Cancer

Li Liao,Yin-Ling Zhang,Ling Deng,Chao Chen,Xiao-Yan Ma,Lisa Andriani,Shao-Ying Yang,Shu-Yuan Hu,Fang-Lin Zhang,Zhi-Min Shao,Da-Qiang Li

DOI: https://doi.org/10.1158/0008-5472.22433349

2023-01-01

Abstract:Supplementary figures and tables

Supplementary Data from Therapeutic Targeting of MDR1 Expression by RORγ Antagonists Resensitizes Cross-Resistant CRPC to Taxane Via Coordinated Induction of Cell Death Programs

Supplementary Data from an Alternatively Spliced P62 Isoform Confers Resistance to Chemotherapy in Breast Cancer

Supplementary Figure S4 from Combination Therapy Targeting Ribosome Biogenesis and Mrna Translation Synergistically Extends Survival in MYC-Driven Lymphoma

Supplementary Fig. 7 from Discovery and Targeting of a Noncanonical Mechanism of Sarcoma Resistance to ADI-PEG20 Mediated by the Microenvironment

Supplementary Figure S3 from Combination Therapy Targeting Ribosome Biogenesis and Mrna Translation Synergistically Extends Survival in MYC-Driven Lymphoma

Supplementary Data from Regorafenib Promotes Antitumor Immunity Via Inhibiting PD-L1 and IDO1 Expression in Melanoma

Supplementary Figures from Targeting Triple-Negative Breast Cancer with Combination Therapy of EGFR CAR T Cells and CDK7 Inhibition

Supplementary Data from Targeting Squalene Epoxidase Interrupts Homologous Recombination Via the ER Stress Response and Promotes Radiotherapy Efficacy

Supplementary Figure 8 from Discovery of a Mutant-Selective Covalent Inhibitor of EGFR That Overcomes T790M-Mediated Resistance in NSCLC

Suppl. Figure 2 from Inhibition of REDD1 Sensitizes Bladder Urothelial Carcinoma to Paclitaxel by Inhibiting Autophagy

Supplementary Data from Inhibition of ACAA1 Restrains Proliferation and Potentiates the Response to CDK4/6 Inhibitors in Triple-Negative Breast Cancer

Supplementary Figure S6 from Targeted Therapy of &Lt;i&gt;tert&lt;/i&gt;-Rearranged Neuroblastoma with BET Bromodomain Inhibitor and Proteasome Inhibitor Combination Therapy

Supplementary Figure 2 from SMAC Mimetic (JP1201) Sensitizes Non–Small Cell Lung Cancers to Multiple Chemotherapy Agents in an IAP-Dependent but TNF-α–Independent Manner

Targeting CXCR4 abrogates resistance to trastuzumab by blocking cell cycle progression and synergizes with docetaxel in breast cancer treatment

Supplementary Data from Targeting Fc Receptor-Mediated Effects and the “don't Eat Me” Signal with an Oncolytic Virus Expressing an Anti-CD47 Antibody to Treat Metastatic Ovarian Cancer

Supplementary Figure 3 from PPARγ Ligand–induced Annexin A1 Expression Determines Chemotherapy Response Via Deubiquitination of Death Domain Kinase RIP in Triple-negative Breast Cancers

Supplementary Tables 1 Through 4 from Mir200c Attenuates P-gp–Mediated MDR and Metastasis by Targeting JNK2/c-Jun Signaling Pathway in Colorectal Cancer

Supplementary Figure 9 from Discovery of a Mutant-Selective Covalent Inhibitor of EGFR That Overcomes T790M-Mediated Resistance in NSCLC

Figure S3 from Retinoic Acid–Related Orphan Receptor C Regulates Proliferation, Glycolysis, and Chemoresistance Via the PD-L1/ITGB6/STAT3 Signaling Axis in Bladder Cancer

Supplementary Data from Galectin-3 Targeted Therapy with a Small Molecule Inhibitor Activates Apoptosis and Enhances Both Chemosensitivity and Radiosensitivity in Papillary Thyroid Cancer

Supplementary Data from Protein Phosphatase 1 Subunit PPP1R14B Stabilizes STMN1 to Promote Progression and Paclitaxel Resistance in Triple-Negative Breast Cancer

Supplementary Figure S6 from Targeted Therapy of &Lt;i>tert</i>-Rearranged Neuroblastoma with BET Bromodomain Inhibitor and Proteasome Inhibitor Combination Therapy